Biotop

Hepatitis B vaccination project in Qinghai, China (Dec.20.2006)

In September 2006, Biotop joined AsianLiverCenter at Stanford University (ALC) and Chinese Foundation for Hepatitis Prevention and Control (CFHPC) to launch the Qinghai vaccination project which will cover 60,000 school age children in 331 schools. The project kicked off on September 5, 2006 and will continue until April 2007. According to ALC, the vaccine completion rate of this ongoing project is expected to reach to 95% with an 80% increase in hepatitis B prevention education knowledge levels. The Qinghai vaccination project has been arranged under the auspices of ALC, CFHPC, ZheShan Foundation and Biotop while a variety of governmental departments and agencies joined forces.

In partnership with CFHPC and provincial CDC and health departments in Qinghai, ALC initiated a catch-up vaccination program in 2004 to vaccinate about 3,500 grade-school children in Sichuan province with Hooksafe™ safety syringes provided by Biotop. In Sep 2006, Biotop commence the second phase of this partnership through the launch of Qinghai vaccination project and education programs which is targeted at the health care workers in Qinghai. Aside from supplying Qinghai vaccine project with safety syringes, Biotop also provided assistance in the training/educational section to update the local staff from local CDC and healthcare work stations with the latest knowledge on Hep B prevention so as to increase the public awareness.

All the participants took photo together after the press conference for the Hep B project kickoff.

Dr. So and Jonathan Chen with students in Qinghai. By April 2007, these kids will no longer have to fear HBV via the catch-up Hep B vaccination and education program.

Ms. Wang Zhao, Director of CFHPC, made an opening speech on the HepB vaccination training section in Gui-De, Qinghai.

About ALC
The Asian Liver Center (ALC) at StanfordUniversity is a non-profit organization that addresses the high incidence of hepatitis B and liver cancer in Asians and Asian-Americans. Founded in 1996, ALC spearheads educational outreach and advocacy efforts in the areas of hepatitis B and liver cancer prevention and treatment. In China specifically, the ALC has collaborated with various Chinese government agencies to develop model HBV vaccination programs providing free hepatitis B vaccination for over school age children. On April 2004 ALC launched the Jade Ribbon Campaign at the National Viral Hepatitis Prevention Conference in Hangzhou, China.

About CFHPC
The China Foundation for Hepatitis Prevention and Control (CFHPC) is a non-governmental organization that was found in 1998 and targeted on Hepatitis B prevention in China. The goal of CFHPC is to conduct the health education and training work as well as to support and facilitate the scientific research and the work related to hepatitis prevention and control in the poor regions, and further to improve and protect people’s health condition in China.